Bevacizumab in advanced lung cancer: state of the art.

about

Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma-induced malignant pleural effusion.The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non‑small cell lung cancer (Review).

P2860

Q47214627-54AB57E0-F205-4E55-A523-C5A019B50DD5 Q52564106-D766FAA7-01E0-4491-9ADC-20A2BA12C6A6

P2860

Bevacizumab in advanced lung cancer: state of the art.

Item

http://www.wikidata.org/entity/Q38641871

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Bevacizumab in advanced lung cancer: state of the art.

@en

type

Item

label

Bevacizumab in advanced lung cancer: state of the art.

@en

prefLabel

Bevacizumab in advanced lung cancer: state of the art.

@en

P1476

Bevacizumab in advanced lung cancer: state of the art.

@en

P2093

Christelle Steinmetz

http://www.w3.org/2001/XMLSchema#string

Gérard Zalcman

http://www.w3.org/2001/XMLSchema#string

Sandra Assoun

http://www.w3.org/2001/XMLSchema#string

Solenn Brosseau

http://www.w3.org/2001/XMLSchema#string

Valérie Gounant

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic Review

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

Tumor angiogenesis: therapeutic implications

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

P31

scholarly article

P356

10.2217/FON-2017-0302

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28812378

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

Bevacizumab in advanced lung cancer: state of the art.

about

P2860

P2860

Bevacizumab in advanced lung cancer: state of the art.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698

P921